Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells

Optimizing oncolytic virotherapy in cancer treatment

(2019) Kevin Harrington et al.   NATURE REVIEWS DRUG DISCOVERY

Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer

(2018) Amanda O. Salzwedel et al.   Oncotarget

Designer Oncolytic Adenovirus: Coming of Age

(2018) Alexander Baker et al.   Cancers

Oncolytic virus-mediated RAS targeting in rhabdomyosarcoma

(2018) Michael P. Phelps et al.   Molecular Therapy-Oncolytics

Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer

(2017) Amanda Rosewell Shaw et al.   MOLECULAR THERAPY

The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration

(2017) J. Manuel Hernández-Hernández et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer

(2017) Mizuho Sato-Dahlman et al.   Oncotarget

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma

(2017) Brian Hutzen et al.   Molecular Therapy-Oncolytics

Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer

(2017) Anwen Howells et al.   Frontiers in Oncology

Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model

(2016) Christine C. Dobson et al.   Oncotarget

Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors

(2014) N. Nishio et al.   CANCER RESEARCH

Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny

(2014) Kiyonori Tanoue et al.   Journal of Translational Medicine

Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group

(2014) Michael J. Burke et al.   PEDIATRIC BLOOD & CANCER

Turning on Myogenin in Muscle: A Paradigm for Understanding Mechanisms of Tissue-Specific Gene Expression

(2012) Herve Faralli et al.   COMPARATIVE AND FUNCTIONAL GENOMICS

Infectivity-selective Oncolytic Adenovirus Developed by High-throughput Screening of Adenovirus-formatted Library

(2012) Yoshiaki Miura et al.   MOLECULAR THERAPY

Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

(2010) Daniel Williamson et al.   JOURNAL OF CLINICAL ONCOLOGY

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

(2009) Simona Ognjanovic et al.   CANCER

Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients

(2009) Iyad Sultan et al.   JOURNAL OF CLINICAL ONCOLOGY

Combinatorial patterns of histone acetylations and methylations in the human genome

(2008) Zhibin Wang et al.   NATURE GENETICS

Downregulation of CD46 During Muscle Differentiation: Implications for Gene Transfer to Human Skeletal Muscle Using Group B Adenoviruses

(2007) Nancy Larochelle et al.   HUMAN GENE THERAPY